What is this that you have done? Episode 1 - An Interview with Dr. Bryan Ardis

Dr. Bryan Ardis completed his Doctorate of Chiropractic from Parker College of Chiropractic in 2004. He graduated in Biology from North Lake College and Brigham Young University.

From 2004 he has owned and operated his own private practices in two different states, Tennessee and Texas.

He retired from clinical practise in 2018. He launched Ardis Labs with his wife Jayne in January of 2019.

In this episode, we discuss the following:

- Why did Dr Ardis start speaking out about the use of the Remdesivir drug in Covid19 patients in 2020?

- Dr Ardis tells us about the death of his father in law in hospital in Feb 2020, and how that affected his family. He explains how that later motivated him to investigate the cases of kidney failure in Covid patients in New York in May 2020.

- Dr Ardis tells us that Remdesivir was the drug recommended by the NIH during May 2020 and that was the drug being used at that time in New York.

- We discuss the results of the 2019 Ebola Trial with Remdesivir and the short 3 month Gilead sponsored trial (Jan – March 2020) of Remdesivir on Covid19 patients. These were the 2 trials used in the approval of Remdesivir at that time.

- Dr Ardis decided to speak out about Remdesivir as he did not want to see any Americans being lied to and harmed by this drug.

- Dr Ardis tells us that the WHO published a statement in November 2020 recommending against the use of Remdesivir for Covid19.

- CMS, the group who insures the elderly and the poor, still to this day , from May of 2020, are incentivizing all hospitals in America if they put all the Covid patients 60 years and over on Remdesivir, CMS will give the hospital a 20% bonus on top of the whole hospital bill, per patient. Why would they do that?

- We discuss the April 2022 decision by the FDA to fully approve Remdesivir for use in children with Covid-19 from 28 days of age and upwards in both hospitalized and non hospitalized settings.

- We discuss how this decision and the upcoming approval for Covid Vaccine for the 0 – 5 year olds, motivated Dr Ardis to come forward in May 2022, with his knowledge regarding snake venom research.

- What is the link between Gilead and GenenTech. In 2011, Gilead brought over many execs and the plants from GenenTech. GenenTech has 7 patented drugs derived from snake venoms to treat cancer patients. What is in Remdesivir?

- Dr Aridis tells us that published side effects of Remdesivir match the published research funded by GenenTech.

- Chinese genetic researchers published the genetic sequence found in Covid Patients in Jan 2020. They said the origin was the Krait snake, King cobra, and bats.

- Same week, Jan 2020, GenenTech publishes a study of a 10 year mapping of King cobra venom, they found 19 venome toxins that kill organs in a human. See reference below.

Websites referenced in the Interview

- CoVenom-19 Documentary. COVENOM-19 VOL. 1 COLD-BLOODED BY DR. BRYAN ARDIS, JONATHAN OTTO . January 2023

https://www.bitchute.com/video/8m1AUmAQYVu1/

-Gilead Press Release. Gilead buys part of Genentech, 2011

https://www.gilead.com/news-and-press/press-room/press-releases/2011/8/gilead-sciences-to-purchase-biologics-process-research-and-clinical--manufacturing-facility-from-genentech

- “A team led by scientists at Genentech, has decoded all 38 chromosomes of the Indian cobra. Our integrated genome–transcriptome analysis identified a minimal set of 19 VST genes that constitute the core venom toxins The comprehensive catalog of the venom proteins presented here should enable drug development.”

Suryamahon K and colleagues (Jan 2020) “The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins” Nature

https://www.nature.com/nature-index/article/10.1038/s41588-019-0559-8

https://www.nature.com/articles/s41588-019-0559-8

- GenenTech Website

https://www.gene.com/

- Chinese paper, identifying the Kreit, Cobra and Bats as possible origins of the virus.

Wei Ji and colleagues. (2020) “Cross‐species transmission of the newly identified coronavirus 2019‐nCoV” J Med Virol

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138088/

- The Dr Ardis Show, Website

https://thedrardisshow.com/